User profiles for Stefania Piconi
 | Stefania PiconiAziende Ospedaliera Alessandro Manzoni Lecco Verified email at asst-lecco.it Cited by 4357 |
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
S Mazzoli, D Trabaironi, SL Caputo, S Piconi, C Blé… - Nature medicine, 1997 - nature.com
HIV-specific mucosal and cellular immunity was analyzed in heterosexual couples discordant
for HIV status in serum and in HIV-unexposed controls. HIV-specific IgA but not IgG was …
for HIV status in serum and in HIV-unexposed controls. HIV-specific IgA but not IgG was …
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells
HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed,
persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to …
persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to …
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima‐media thickness
S Piconi, D Trabattoni, C Luraghi, E Perilli… - The FASEB …, 2009 - Wiley Online Library
Several cohort studies reported a relation of cardiovascular events and periodontal disease.
In particular, Porphyromonas gingivalis is associated with the development of …
In particular, Porphyromonas gingivalis is associated with the development of …
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders
S Piconi, S Parisotto, G Rizzardini… - Blood, The Journal …, 2011 - ashpublications.org
Despite optimal suppression of HIV replication, restoration of CD4 + T cells is not always
achieved in antiretroviral therapy–treated individuals. Defective CD4 recovery in immunologic …
achieved in antiretroviral therapy–treated individuals. Defective CD4 recovery in immunologic …
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy
Background: Persistently reduced CD4+ T-lymphocyte counts in the face of undetectable HIV
viremia are seen in a sizable percentage of HIV-infected patients undergoing antiretroviral …
viremia are seen in a sizable percentage of HIV-infected patients undergoing antiretroviral …
[HTML][HTML] The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and …
Background Geriatric Patients Living with HIV/AIDS (GEPPO) is a new prospective observational
multicentre cohort consisting of all the HIV-positive geriatric patients being treated at 10 …
multicentre cohort consisting of all the HIV-positive geriatric patients being treated at 10 …
Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical …
…, L Stoppini, N Ferracchiato, S Piconi… - JAMA network …, 2021 - jamanetwork.com
Importance Convalescent plasma (CP) has been generally unsuccessful in preventing
worsening of respiratory failure or death in hospitalized patients with COVID-19 pneumonia. …
worsening of respiratory failure or death in hospitalized patients with COVID-19 pneumonia. …
Probiotics reduce gut microbial translocation and improve adult atopic dermatitis
…, E Ricci, A Fusi, E De Vecchi, S Piconi… - Journal of clinical …, 2012 - journals.lww.com
Background: It has been suggested that probiotics modulate atopic dermatitis (AD) progression,
but no data are actually available on their mechanisms of action and on their ability to …
but no data are actually available on their mechanisms of action and on their ability to …
Immune profiles of patients with chronic idiopathic urticaria
Background: The immunologic characterization of chronic idiopathic urticaria (CIU) is still
incomplete. In particular, it is not known if positivity to the intradermal autologous serum skin …
incomplete. In particular, it is not known if positivity to the intradermal autologous serum skin …
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects
…, P Kiama, L Lopalco, C Barass, S Piconi… - JAIDS Journal of …, 2002 - journals.lww.com
There is an urgent need for a universally effective HIV-1 vaccine, but whether a vaccine will
be able to protect against HIV-1 of different clades is a significant concern. IgA from HIV-1-…
be able to protect against HIV-1 of different clades is a significant concern. IgA from HIV-1-…
